News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
124,808 Results
Type
Article (4246)
Company Profile (94)
Press Release (120468)
Section
Business (41995)
Career Advice (206)
Deals (6148)
Drug Delivery (13)
Drug Development (17385)
Employer Resources (18)
FDA (1486)
Job Trends (2767)
News (66003)
Policy (3646)
Tag
Academia (286)
Africa (135)
Alabama (16)
Alliances (11336)
Alzheimer's disease (245)
Approvals (1466)
Arizona (14)
Asia (8259)
Australia (1919)
Bankruptcy (37)
Best Places to Work (2163)
Biotechnology (88)
Breast cancer (14)
C2C Services and Suppliers (4968)
California (623)
Canada (253)
Cancer (101)
Career advice (194)
CAR-T (13)
Cell therapy (43)
China (31)
Clinical research (13305)
Collaboration (51)
Compensation (14)
Connecticut (20)
COVID-19 (409)
Cystic fibrosis (15)
Data (79)
Diabetes (13)
Diagnostics (641)
Drug discovery (12)
Earnings (11883)
Employer resources (18)
Europe (17825)
Events (23446)
Executive appointments (59)
FDA (1529)
Florida (53)
Funding (40)
Gene therapy (21)
GLP-1 (89)
Government (331)
Healthcare (1480)
Hotbed/Location (89062)
Illinois (71)
Indiana (41)
Infectious disease (411)
Inflammatory bowel disease (31)
Interviews (16)
IPO (2856)
Job creations (665)
Job search strategy (184)
Layoffs (30)
Legal (632)
Manufacturing (26)
Maryland (70)
Massachusetts (417)
Medical device (388)
Medtech (388)
Mergers & acquisitions (3308)
Metabolic disorders (38)
Michigan (42)
Minnesota (50)
Neuroscience (283)
New Jersey (173)
New York (158)
NextGen Class of 2024 (842)
Non-profit (267)
North Carolina (146)
Northern California (260)
Obesity (24)
Ohio (22)
Opinion (36)
Parkinson's disease (11)
Patents (21)
Pennsylvania (169)
People (15910)
Phase I (5254)
Phase II (6349)
Phase III (3286)
Pipeline (30)
Policy (19)
Postmarket research (209)
Preclinical (2250)
Press Release (51)
Radiopharmaceuticals (44)
Rare diseases (28)
Real estate (1438)
Regulatory (2793)
Reports (11)
Research institute (297)
Resumes & cover letters (18)
South America (198)
Southern California (270)
Startups (980)
Texas (46)
United States (2318)
Vaccines (30)
Washington State (169)
Weight loss (16)
Date
Today (24)
Last 7 days (126)
Last 30 days (676)
Last 365 days (9366)
2024 (6808)
2023 (9880)
2022 (12009)
2021 (12663)
2020 (9869)
2019 (6673)
2018 (5275)
2017 (6074)
2016 (5598)
2015 (6441)
2014 (4927)
2013 (4063)
2012 (4397)
2011 (4873)
2010 (4518)
124,808 Results for "lfb biotechnologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
LFB Plasma Joins Plasma Protein Therapeutics Association (PPTA)
LFB Plasma, a US-based plasma collection company and subsidiary of the LFB Group, a leading European company providing plasma-derived products to healthcare professionals, announces joining the Plasma Protein Therapeutics Association.
September 9, 2022
·
2 min read
LFB Announces the Approval of CEVENFACTA® (eptacog beta) in the European Union
LFB today announced that the European Medicines Agency (EMA) has granted on July 15th a Marketing Authorisation for CEVENFACTA® (eptacog beta), as the first new bypassing agent in over 20 years.
July 25, 2022
·
5 min read
Deals
Arbor Biotechnologies Announces Acquisition of Serendipity
Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, announced the acquisition of Serendipity Biosciences, a private biotechnology company focused on the discovery of unique gene editing technologies.
May 8, 2024
·
3 min read
BioMidwest
Anbio Biotechnology to Showcase at ADLM 2024 with Evolved In Vitro Diagnostic Solutions
Anbio Biotechnology (“Anbio”), a leading global diagnostic solution provider, is excited to announce its participation in the ADLM 2024 Clinical Lab Expo (formerly the AACC Clinical Lab Expo).
July 1, 2024
·
1 min read
Biotech Bay
Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
Adverum Biotechnologies, Inc. today announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will participate in a fireside chat at TD Cowen’s Genetic Medicines & RNA Summit on Friday, June 21, 2024 at 10:00 a.m. ET.
June 18, 2024
·
1 min read
Press Releases
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation
Sana Biotechnology, Inc. today highlighted that Nature Biotechnology has published a paper titled “Young glial progenitor cells competitively replace aged and diseased human glia in the adult chimeric mouse brain.”
May 21, 2024
·
6 min read
BioMidwest
Battelle and Allonnia to Co-Host 2025 Bioremediation and Environmental Biotechnology Conference
Battelle is pleased to announce that it will co-host the Seventh International Symposium on Bioremediation and Environmental Biotechnology with Allonnia.
June 3, 2024
·
2 min read
Business
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
Adaptive Biotechnologies Corporation, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, reported financial results for the quarter ended March 31, 2024.
May 7, 2024
·
15 min read
Business
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., the leader in enabling the development and supply of better treatments for patients worldwide, entered a strategic partnership to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies.
May 8, 2024
·
2 min read
Biotech Bay
Vir Biotechnology to Host 2024 Annual Meeting of Stockholders
Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders that it will hold its 2024 Annual Meeting of Stockholders on Wednesday, May 29, 2024, at 9:00 a.m. PT.
May 23, 2024
·
1 min read
1 of 12,481
Next
